6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide
C14H16ClN5O2S — CID 118611172
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide
6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide (PubChem CID 118611172) has the molecular formula C14H16ClN5O2S and a molecular weight of 353.84 g/mol. Its IUPAC name is 6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 118611172 |
| Molecular Formula | C14H16ClN5O2S |
| Molecular Weight | 353.84 g/mol |
| Exact Mass | 353.07 |
| IUPAC Name | 6-chloro-N-[(2S)-3-(6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide |
| SMILES | O=C(NC[C@H](O)CN1CCc2ncsc2C1)c1cc(Cl)ncn1 |
| InChI | InChI=1S/C14H16ClN5O2S/c15-13-3-11(17-7-18-13)14(22)16-4-9(21)5-20-2-1-10-12(6-20)23-8-19-10/h3,7-9,21H,1-2,4-6H2,(H,16,22)/t9-/m0/s1 |
| InChIKey | KIFCNKSAELYDLA-VIFPVBQESA-N |
| XLogP | 0.74 |
| TPSA | 91.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 353.84 |
| LogP ≤ 5 | 0.74 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118611172 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.